Pan-cancer analysis of whole genomes
2020 · Nature · 3,205 citations
https://doi.org/10.1038/s41586-020-1969-6
R
Roberto Salgado
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
602
Papers
37.8K
Citations
82
h-index
188
i10-index
Roberto Salgado is an academic researcher from Ziekenhuisnetwerk Antwerpen Stuivenberg. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Cancer Genomics and Diagnostics & Breast Cancer Treatment Studies. The author has an h-index of 82, co-authored 512 publications.
ORCID: 0000-0002-1110-3801Papers by this author
worksPrognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98
2013 · Journal of Clinical Oncology · 1,618 citations
https://doi.org/10.1200/jco.2011.41.0902
The evolutionary history of 2,658 cancers
2020 · Nature · 1,075 citations
https://doi.org/10.1038/s41586-019-1907-7
Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis
2018 · Nature Medicine · 971 citations
https://doi.org/10.1038/s41591-018-0078-7
Patterns of somatic structural variation in human cancer genomes
2020 · Nature · 963 citations
https://doi.org/10.1038/s41586-019-1913-9
Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
2020 · Nature · 648 citations
https://doi.org/10.1038/s41586-020-1965-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat